Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 
 
 

High-density protein microarray chip for validation of antibody specificity
August 2011
SHARING OPTIONS:

OriGene Technologies Inc.
 
OriGene introduces its major breakthrough technology, the High-Density Protein Microarray Chip, for the quality control of its TrueMAB monoclonal antibodies. The new chip enables OriGene to screen monoclonal antibodies against 10,000 human proteins to provide the most specific monoclonal antibodies. The antibodies validated with the OriGene High-Density Protein Microarray Chip will enable IVD manufacturers to develop the most accurate and specific immunoassays for clinical applications.
 
OriGene Technologies Inc.
(888) 267-4436
www.origene.com

Back

PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.